factual

Credibility built on journal publication and NCCN guidance

The company built credibility by publishing its trial data in major journals like JAMA and by earning a National Comprehensive Cancer Network Category 1 rating, a standard-of-care indication.

factualpending

Speaker

Bill

Evidence Quote

“We're rated as a NCCN. That's the National Comprehensive Cancer Network. Category 1”

Source

Novocure: Using Physics to Fight Cancer— Business Breakdowns
Created: 11/19/2026, 2:27:17 AM

Your notes

Loading notes...